Multiple Myeloma (MM) Completed Phase 2 Trials for Tipifarnib (DB04960)

Also known as: MULTIPLE MYELOMA (MM) / Multiple myeloma / Myeloma, Multiple / Multiple Myelomas / Multiple Myeloma(MM) / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

DBCOND0040908 (Multiple Myeloma (MM))Completed2 IdentifierTitlePurposeDrugs
NCT00012350Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple MyelomaTreatment